Close Menu
    Latest Posts

    Pfizer Lyme disease vaccine fails trial, company to seek FDA approval

    March 23, 2026

    Paraguay signals neutral stance with pause in easing cycle

    March 23, 2026

    Gold enters bear market as Bitcoin ETFs attract record inflows

    March 23, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Pfizer Lyme disease vaccine fails trial, company to seek FDA approval
    • Paraguay signals neutral stance with pause in easing cycle
    • Gold enters bear market as Bitcoin ETFs attract record inflows
    • Amazon’s Prime Day Shift: Why Moving It to June Matters
    • CLARITY Act Update: Crypto and Bank Reps Head to Capitol Hill to Review Stablecoin Deal as Details Remain Under Wraps
    • US, TotalEnergies to shift nearly $1 billion from wind to oil and gas
    • Rivian’s Making a Big Pivot, and the Results Could Be Huge
    • Fed's Miran Says Policy Can't Be Made on Short-Term Headlines
    Facebook X (Twitter) Instagram
    MoneyLister – Smart Investing & Financial NewsMoneyLister – Smart Investing & Financial News
    Tuesday, March 24
    • Home
    • Banking
    • Business
    • Crypto
    • Economy
    • Fintech
    • Investing
    • Markets
    • Stocks
    MoneyLister – Smart Investing & Financial NewsMoneyLister – Smart Investing & Financial News
    Home»Investing»Beer Stocks are Breaking Out (BUD, HEINY, CABGY)
    Investing

    Beer Stocks are Breaking Out (BUD, HEINY, CABGY)

    AdminBy AdminFebruary 27, 2026No Comments5 Mins Read
    Share Facebook Twitter Pinterest Copy Link LinkedIn Tumblr Email VKontakte Telegram
    Higher Open Called For Taiwan Stock Market
    Share
    Facebook Twitter Pinterest Email Copy Link

    A powerful but underappreciated development is unfolding, as select beer stocks, which have struggled in recent years quietly gain momentum, supported by improving fundamentals, reasonable valuations, and strong price momentum.

    Three stocks where this is accelerating are Heineken (HEINY), AnheuserBusch InBev (BUD), and Carlsberg (CABGY). HEINY and CABGY currently hold a Zacks Rank #1 (Strong Buy), while BUD carries a Zacks Rank #2 (Buy), reflecting rising analyst sentiment on the group.

    The core thesis is straightforward: multiple expansion from a low base, driven by earnings growth and capital flows seeking depressed opportunities.

    When earnings per share are growing in the teens while revenue expands at only single-digit rates, the story is about margin expansion and capital return. For mature global beverage companies trading at mid-teens forward P/E multiples, well below the S&P 500’s roughly 21x, it does not take heroic assumptions to justify a re-rating. It simply requires a narrative shift from “secular decline” to “stable, efficient, and returning cash.”

    Image Source: Zacks Investment Research

    Alcohol Stock Under Ownership Is Driving the Early Move

    Alcohol stocks were aggressively de-rated over the last several years. Concerns around GLP-1 drugs, sobriety trends among younger consumers, cannabis substitution, and slowing developed market consumption drove a broad “secular decline” thesis. As a result, active managers underweighted the group.

    However, it seems that those expectations have been priced too heavily into these stocks, and as good businesses do, they pivoted. With few investors meaningfully exposed, incremental buying is having an outsized impact on price. This mechanical under ownership dynamic is often how early-stage rotations begin.

    The pattern is consistent with what is currently unfolding: improving price action before a major earnings revision cycle. Buy side capital typically moves first and sell side upgrades often follow. If revision breadth begins to widen in coming quarters, that would provide confirmation of a more durable re-rating.

    Earnings Upgrades Drive HEINY, BUD and CABGY Shares Higher

    Earnings estimates appear to be in the early stages of an upgrade cycle, and that dynamic is often the fuel behind sustained price momentum. What makes the setup particularly compelling is the quality of the growth profile. Revenue is expanding in the mid-single digits, while earnings are growing in the teens, a clear sign of operating leverage improvement.

    That type of divergence between sales and EPS tells a specific story. These businesses are not reliant on aggressive volume acceleration. Instead, margin expansion, pricing power, mix shift toward premium offerings, and disciplined cost control are driving incremental profitability. When fixed costs are largely covered and incremental revenue drops through at a higher margin, even modest top line growth can translate into outsized earnings gains.

    The revisions trend confirms that the underlying fundamentals are improving. For Heineken, current year earnings estimates have climbed 5.3% over the past month, while next year’s consensus has moved 4.6% higher. That magnitude of upward revision in a defensive staple name is meaningful. It signals growing confidence that margin gains are likely durable rather than temporary. Both Carlsberg and AnheuserBusch InBev are showing similar inflections in estimate trends as well.

    Image Source: Zacks Investment Research

    Shares Break Out on Strong Momentum with Technical Confirmation

    Price action supports the improving fundamental narrative. All three stocks have begun building constructive technical setups, reflecting institutional accumulation.

    In early re-rating cycles, momentum frequently precedes broad earnings upgrades. If fundamentals continue to stabilize and margins remain firm, the current strength may extend for multiple quarters before valuations fully normalize.

    In the chart below, we can see AnheuserBusch InBev stock broke out from a stage one base to start the year, which led to a rigorous rally in the first six weeks of 2026. Then in the last two weeks, shares have consolidated into a continuation pattern and are today breaking out again. This is a pattern shared in Heineken and Carlsberg stocks as well.

    Image Source: TradingView

    Should Investors Buy Shares in BUD, CAGBY and HEINY?

    The combination of under ownership, better-than-feared fundamentals, margin expansion, reasonable valuations, and improving technical setups is not an accident. It is often the exact environment that sustains momentum before the broader market fully recognizes the shift.

    For investors looking beyond crowded trades and stretched multiples, Heineken, AnheuserBusch InBev, and Carlsberg represent a compelling setup: stable global franchises, expanding margins, and the potential for continued multiple expansion from a low base.

    Zacks’ Research Chief Names “Stock Most Likely to Double”

    Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

    This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company’s customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Hims & Hers Health, which shot up +209%.

    Free: See Our Top Stock And 4 Runners Up

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

    Anheuser-Busch InBev SA/NV (BUD) : Free Stock Analysis Report

    Carlsberg AS (CABGY) : Free Stock Analysis Report

    Heineken NV (HEINY) : Free Stock Analysis Report

    This article originally published on Zacks Investment Research (zacks.com).

    Zacks Investment Research

    The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

    Beer breaking BUD CABGY HEINY Stocks
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Telegram Copy Link
    Admin
    • Website

    Related Posts

    Investing

    Amazon’s Prime Day Shift: Why Moving It to June Matters

    March 23, 2026
    Investing

    Wealthy consumers invest in jewelry amid rising uncertainty, market volatility

    March 22, 2026
    Stocks

    Stocks Plunge on US Plans to Escalate Iran War

    March 22, 2026
    Investing

    History says these 2 overlooked asset classes are the only real shield against 1970s-style stagflation

    March 21, 2026
    Investing

    You Don’t Have to Take Required Minimum Distributions (RMDs) From These Accounts in 2026

    March 20, 2026
    Investing

    Betting scandals leave pro sports just one way to save the $165 billion gaming market

    March 19, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Pfizer Lyme disease vaccine fails trial, company to seek FDA approval

    March 23, 2026

    Paraguay signals neutral stance with pause in easing cycle

    March 23, 2026

    Gold enters bear market as Bitcoin ETFs attract record inflows

    March 23, 2026

    Amazon’s Prime Day Shift: Why Moving It to June Matters

    March 23, 2026
    Latest Posts

    Subscribe to News

    Get the latest sports news from NewsSite about world, sports and politics.

    About Us

    Welcome to MoneyLister.com — your trusted source for reliable insights in the world of finance, investing, and digital assets.

    At MoneyLister, our mission is simple: to make complex financial topics easy to understand and accessible to everyone. Whether you're a beginner exploring cryptocurrency, an investor tracking the stock market, or a professional staying updated on global business trends, we provide clear, informative, and up-to-date content to help you stay ahead.

    Facebook X (Twitter) Instagram Pinterest YouTube
    Latest Posts

    Pfizer Lyme disease vaccine fails trial, company to seek FDA approval

    March 23, 2026

    Paraguay signals neutral stance with pause in easing cycle

    March 23, 2026

    Gold enters bear market as Bitcoin ETFs attract record inflows

    March 23, 2026
    Recent Posts
    • Pfizer Lyme disease vaccine fails trial, company to seek FDA approval
    • Paraguay signals neutral stance with pause in easing cycle
    • Gold enters bear market as Bitcoin ETFs attract record inflows
    • Amazon’s Prime Day Shift: Why Moving It to June Matters
    • CLARITY Act Update: Crypto and Bank Reps Head to Capitol Hill to Review Stablecoin Deal as Details Remain Under Wraps
    © 2026 moneylister. Designed by Pro.
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Disclaimer

    Type above and press Enter to search. Press Esc to cancel.